Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Guardian Pharmacy Services, Inc., Surgery Partners or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Guardian Pharmacy Services, Inc., Surgery Partners and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Guardian Pharmacy Services, Inc., Surgery Partners and Inc.

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Latest Health Care Providers & Services and Guardian Pharmacy Services, Inc., Surgery Partners, Inc. Stock News

As of February 18, 2026, Guardian Pharmacy Services, Inc. had a $2.1 billion market capitalization, compared to the Health Care Providers & Services median of $1.3 million. Guardian Pharmacy Services, Inc.’s stock is up 9.3% in 2026, down 4.9% in the previous five trading days and up 66.23% in the past year.

Currently, Guardian Pharmacy Services, Inc.’s price-earnings ratio is 117.7. Guardian Pharmacy Services, Inc.’s trailing 12-month revenue is $1.4 billion with a 2.9% net profit margin. Year-over-year quarterly sales growth most recently was 20.0%. Analysts expect adjusted earnings to reach $0.983 per share for the current fiscal year. Guardian Pharmacy Services, Inc. does not currently pay a dividend.

As of February 18, 2026, Surgery Partners, Inc. had a $2.1 billion market cap, putting it in the 56th percentile of all stocks. Surgery Partners, Inc.’s stock is up 1.5% in 2026, up 4.5% in the previous five trading days and down 38.19% in the past year.

Currently, Surgery Partners, Inc. does not have a price-earnings ratio. Surgery Partners, Inc.’s trailing 12-month revenue is $3.3 billion with a -5.2% net profit margin. Year-over-year quarterly sales growth most recently was 6.6%. Analysts expect adjusted earnings to reach $0.637 per share for the current fiscal year. Surgery Partners, Inc. does not currently pay a dividend.

How We Compare Guardian Pharmacy Services, Inc., Surgery Partners and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Guardian Pharmacy Services, Inc., Surgery Partners and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Guardian Pharmacy Services, Inc., Surgery Partners and Inc. Stock Value Grades

Company	Ticker	Value
Guardian Pharmacy Services, Inc.	GRDN	F
Surgery Partners, Inc.	SGRY	B

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Guardian Pharmacy Services, Inc. has a Value Score of 16, which is Ultra Expensive. Surgery Partners, Inc. has a Value Score of 75, which is Value.

The Value Stock Winner: Surgery Partners, Inc.

As you can clearly see from the Value Grade breakdown above, Surgery Partners, Inc. is considered to have better value than Guardian Pharmacy Services, Inc.. For investors who focus solely on a company’s valuation, Surgery Partners, Inc. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Guardian Pharmacy Services, Inc., Surgery Partners and Inc. Growth Grades

Company	Ticker	Growth
Guardian Pharmacy Services, Inc.	GRDN	A
Surgery Partners, Inc.	SGRY	A

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Guardian Pharmacy Services, Inc. has a Growth Score of 91, which is Very Strong. Surgery Partners, Inc. has a Growth Score of 91, which is Very Strong.

The Growth Grade Winner: It’s a Tie!

Looking at the Growth Grade breakdown above, both Guardian Pharmacy Services, Inc., Surgery Partners and Inc. have a grade of A. For investors who focus solely on a company’s upward growth, further research should be conducted into both companies’ other financial metrics before deciding whether to invest.

Guardian Pharmacy Services, Inc., Surgery Partners and Inc.’s Momentum Grades

Company	Ticker	Momentum
Guardian Pharmacy Services, Inc.	GRDN	B
Surgery Partners, Inc.	SGRY	D

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Guardian Pharmacy Services, Inc. has a Momentum Score of 79, which is Strong. Surgery Partners, Inc. has a Momentum Score of 23, which is Weak.

The Momentum Grade Winner: Guardian Pharmacy Services, Inc.

As you can clearly see from the Momentum Grade breakdown above, Guardian Pharmacy Services, Inc. is considered to have stronger momentum compared to Surgery Partners, Inc.. For those specifically looking for companies that have stronger momentum compared to other companies in the same industry, Guardian Pharmacy Services, Inc. could be a good stock to invest in. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Guardian Pharmacy Services, Inc., Surgery Partners and Inc. Grades

In addition to Value, Momentum and Growth, A+ Investor also provides grades for Estimate Revisions and Quality.

Earnings estimate revisions scores take into account the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, surprises beget further surprises‐or at least continued sales growth (the exact opposite is generally true, too).

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Guardian Pharmacy Services, Inc., Surgery Partners and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Guardian Pharmacy Services, Inc., Surgery Partners or Inc. Stock?

Overall, Guardian Pharmacy Services, Inc. stock has a Value Score of 16, Growth Score of 91 and Momentum Score of 79.

Surgery Partners, Inc. stock has a Value Score of 75, Growth Score of 91 and Momentum Score of 23.

Comparing Guardian Pharmacy Services, Inc., Surgery Partners and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.